These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30987056)

  • 1. Quantitative Analysis of Tozadenant Using Liquid Chromatography-Mass Spectrometric Method in Rat Plasma and Its Human Pharmacokinetics Prediction Using Physiologically Based Pharmacokinetic Modeling.
    Lee BI; Park MH; Shin SH; Byeon JJ; Park Y; Kim N; Choi J; Shin YG
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30987056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualification and application of liquid chromatography-quadrupole time-of-flight mass spectrometric method for the determination of carisbamate in rat plasma and prediction of its human pharmacokinetics using physiologically based pharmacokinetic modeling.
    Lee BI; Lim JH; Park MH; Shin SH; Byeon JJ; Choi JM; Park SJ; Park MJ; Park Y; Shin YG
    Transl Clin Pharmacol; 2020 Sep; 28(3):147-159. PubMed ID: 33062628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine 2A receptor occupancy by tozadenant and preladenant in rhesus monkeys.
    Barret O; Hannestad J; Alagille D; Vala C; Tavares A; Papin C; Morley T; Fowles K; Lee H; Seibyl J; Tytgat D; Laruelle M; Tamagnan G
    J Nucl Med; 2014 Oct; 55(10):1712-8. PubMed ID: 25082853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and metabolism of [
    Mancel V; Mathy FX; Boulanger P; English S; Croft M; Kenney C; Knott T; Stockis A; Bani M
    Xenobiotica; 2017 Aug; 47(8):705-718. PubMed ID: 27489076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial.
    Hauser RA; Olanow CW; Kieburtz KD; Pourcher E; Docu-Axelerad A; Lew M; Kozyolkin O; Neale A; Resburg C; Meya U; Kenney C; Bandak S
    Lancet Neurol; 2014 Aug; 13(8):767-76. PubMed ID: 25008546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of verapamil on the pharmacokinetics and hepatobiliary disposition of fexofenadine in pigs.
    Sjögren E; Hedeland M; Bondesson U; Lennernäs H
    Eur J Pharm Sci; 2014 Jun; 57():214-23. PubMed ID: 24075962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of Novel Furoxan/Coumarin Hybrids in Rats Using LC-MS/MS Method and Physiologically Based Pharmacokinetic Model.
    Yuan Y; Li Z; Wang K; Zhang S; He Q; Liu L; Tang Z; Zhu X; Chen Y; Cai W; Peng C; Xiang X
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shared learning from a physiologically based pharmacokinetic modeling strategy for human pharmacokinetics prediction through retrospective analysis of Genentech compounds.
    Mao J; Ma F; Yu J; Bruyn T; Ning M; Bowman C; Chen Y
    Biopharm Drug Dispos; 2023 Aug; 44(4):315-334. PubMed ID: 37160730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment and Confirmation of Species Difference in Nonlinear Pharmacokinetics of Atipamezole with Physiologically Based Pharmacokinetic Modeling.
    Li Z; Gao Y; Yang C; Xiang Y; Zhang W; Zhang T; Su R; Lu C; Zhuang X
    Drug Metab Dispos; 2020 Jan; 48(1):41-51. PubMed ID: 31699808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of oral pharmacokinetics of cMet kinase inhibitors in humans: physiologically based pharmacokinetic model versus traditional one-compartment model.
    Yamazaki S; Skaptason J; Romero D; Vekich S; Jones HM; Tan W; Wilner KD; Koudriakova T
    Drug Metab Dispos; 2011 Mar; 39(3):383-93. PubMed ID: 21098644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatography-tandem mass spectrometric assay for the quantitative determination of the tyrosine kinase inhibitor quizartinib in mouse plasma using salting-out liquid-liquid extraction.
    Retmana IA; Wang J; Schinkel AH; Schellens JHM; Beijnen JH; Sparidans RW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():300-305. PubMed ID: 28772226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Method development for quantification of quizartinib in rat plasma by liquid chromatography/tandem mass spectrometry for pharmacokinetic application.
    Ezzeldin E; Iqbal M; Mostafa G; Al-Rashood KA; El-Nahhas T
    Biomed Chromatogr; 2018 Mar; 32(3):. PubMed ID: 29131376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologically Based Pharmacokinetic Models Can Be Used to Predict the Unique Nonlinear Absorption Profiles of Vismodegib.
    Lin L; Wright MR; Hop CECA; Wong H
    Drug Metab Dispos; 2022 Sep; 50(9):1170-1181. PubMed ID: 35779865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel physiologically based pharmacokinetic modeling of patupilone for human pharmacokinetic predictions.
    Xia B; Heimbach T; Lin TH; He H; Wang Y; Tan E
    Cancer Chemother Pharmacol; 2012 Jun; 69(6):1567-82. PubMed ID: 22526410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Translational Physiologically Based Pharmacokinetic Model for Antibody-Drug Conjugates: a Case Study with T-DM1.
    Khot A; Tibbitts J; Rock D; Shah DK
    AAPS J; 2017 Nov; 19(6):1715-1734. PubMed ID: 28808917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting In Vivo Target Occupancy (TO) Profiles via Physiologically Based Pharmacokinetic-TO Modeling of Warfarin Pharmacokinetics in Blood: Importance of Low Dose Data and Prediction of Stereoselective Target Interactions.
    Lee W; Kim MS; Kim J; Aoki Y; Sugiyama Y
    Drug Metab Dispos; 2023 Sep; 51(9):1145-1156. PubMed ID: 36914276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiosynthesis and In Vitro Evaluation of [
    Humpert S; Schneider D; Lang M; Schulze A; Neumaier F; Holschbach M; Bier D; Neumaier B
    Molecules; 2024 Feb; 29(5):. PubMed ID: 38474602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Preclinical Pharmacokinetic Properties and Prediction of Human PK Using a Physiologically Based Pharmacokinetic Model for a Novel Anti-Arrhythmic Agent Sulcardine Sulfate.
    Ren C; Wang Y; Zhang M; Kong D; Ning C; Cheng Y; Bian Y; Sun M; Su S; Wang Y; Zhang Y; Lu Y; Li N; Zhao D; Chen X
    Pharm Res; 2021 Nov; 38(11):1847-1862. PubMed ID: 34773182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of highly selective sigma-1 receptor antagonist CM304 using liquid chromatography tandem mass spectrometry and its application to a pre-clinical pharmacokinetic study.
    Avery BA; Vuppala PK; Jamalapuram S; Sharma A; Mesangeau C; Chin FT; McCurdy CR
    Drug Test Anal; 2017 Aug; 9(8):1236-1242. PubMed ID: 28039926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of PD 0332991 in mouse plasma using automated micro-sample processing and microbore liquid chromatography coupled with tandem mass spectrometry.
    Smith D; Tella M; Rahavendran SV; Shen Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Oct; 879(27):2860-5. PubMed ID: 21889427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.